Publications
Export 9 results:
Filters: Author is Dupré, Nicolas [Clear All Filters]
Effects of Antiparkinson Medication on Cognition in Parkinson's Disease: A Systematic Review. Can J Neurol Sci. 2018;45(4):375-404.
Goal management training ® home-based approach for mild cognitive impairment in Parkinson's disease: a multiple baseline case report. Neurocase. 2018;24(5-6):276-286.
The influence of vascular risk factors on cognitive function in early Parkinson's disease. Int J Geriatr Psychiatry. 2018;33(2):288-297.
Misfolded SOD1 pathology in sporadic Amyotrophic Lateral Sclerosis. Sci Rep. 2018;8(1):14223.
Smoking history is associated to cognitive impairment in Parkinson's disease. Aging Ment Health. 2017;21(3):322-326.
From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathol Commun. 2016;4(1):70.
Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold-induced myotonia in French Canadians. J Physiol (Lond). 2012;590(11):2629-44.
Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB-mediated pathogenic pathways. J Exp Med. 2011;208(12):2429-47.
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc Natl Acad Sci USA. 2009;106(51):21777-82.
